Mabwell Bioscience
Public companyCN1 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechDeveloped the IL-11 antibody 9MW3811, explored for age-related diseases and licensed to Calico. | Developed the IL-11 antibody 9MW3811, explored for age-related diseases and licensed to Calico. | calicolabs.com |
Events
| Date | Event | ||
|---|---|---|---|
| Jun 26, 2025 | Calico licenses Mabwell's IL-11 antibody for age-related diseasecalicolabs.com· Deal· Longevity biotech | Longevity biotech | Deal |
About
- Source
- calicolabs.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Mabwell BioscienceCompany in Longevity biotech: Joined a field, Developed the IL-11 antibody 9MW3811, explored for age-related diseases and licensed to Calico. | seed | calicolabs.com |
| Sep 25, 2026 | Mabwell BioscienceCompany: Added | seed | calicolabs.com |